{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:14:47Z","timestamp":1783484087348,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.clbc.2026.05.009","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:53:03Z","timestamp":1780415583000},"page":"56-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Clinical Impact of Not Performing Axillary Lymph Node Dissection in pN+sn Breast Cancer Patients Undergoing Total Mastectomy"],"prefix":"10.1016","volume":"26","author":[{"given":"Beatriz","family":"Maganinho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara","family":"Peleteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Lu\u00eds","family":"Fougo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.clbc.2026.05.009_bib0001","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs No axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.clbc.2026.05.009_bib0002","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","article-title":"Omitting axillary dissection in breast cancer with sentinel-node metastases","volume":"390","author":"de Boniface","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clbc.2026.05.009_bib0003","doi-asserted-by":"crossref","first-page":"40","DOI":"10.6004\/jnccn.2020.7597","article-title":"Impact of axillary dissection among patients with sentinel node-positive breast cancer undergoing mastectomy","volume":"19","author":"Sun","year":"2021","journal-title":"J Natl Compr Cancer Netk"},{"issue":"1","key":"10.1016\/j.clbc.2026.05.009_bib0004","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-023-02888-z","article-title":"Risk factors of non-sentinel lymph node metastasis in breast cancer with 1\u20132 sentinel lymph node macrometastases underwent total mastectomy: a case-control study","volume":"21","author":"Huang","year":"2023","journal-title":"World J Surg Oncol"},{"issue":"8","key":"10.1016\/j.clbc.2026.05.009_bib0005","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/wjs.12690","article-title":"Axillary management for patients undergoing total mastectomy and a positive sentinel lymph node: is axillary dissection necessary?","volume":"49","author":"Addie","year":"2025","journal-title":"World J Surg"},{"issue":"9","key":"10.1016\/j.clbc.2026.05.009_bib0006","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1245\/s10434-022-11866-w","article-title":"Preservation of axillary lymph nodes compared with complete dissection in T1-2 breast cancer patients presenting one or two metastatic sentinel lymph nodes: the SINODAR-ONE multicenter randomized clinical trial","volume":"29","author":"Tinterri","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2026.05.009_bib0007","first-page":"308","article-title":"The clinical impact of the application of a clinical decision rule to a population of sentinel node positive breast cancer patients","volume":"28","author":"Pereira","year":"2023","journal-title":"Surg Chron"},{"key":"10.1016\/j.clbc.2026.05.009_bib0008","article-title":"A novel nomogram for decision-making assistance on exemption of axillary lymph node dissection in T1\u20132 breast cancer with only one sentinel lymph node metastasis","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2026.05.009_bib0009","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.breast.2010.10.009","article-title":"Validating the MSKCC nomogram and a clinical decision rule in the prediction of non-sentinel node metastases in a Portuguese population of breast cancer patients","volume":"20","author":"Fougo","year":"2011","journal-title":"Breast"},{"issue":"9","key":"10.1016\/j.clbc.2026.05.009_bib0010","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1245\/s10434-023-13698-8","article-title":"De-implementation of axillary dissection in women undergoing mastectomy for breast cancer","volume":"30","author":"Leonard","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2026.05.009_bib0011","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijsu.2015.01.006","article-title":"T-stage and positive sentinel nodes ratio are the useful factors to predict non-sentinel node metastasis in breast cancer patients with macro-metastasis in the sentinel node","volume":"14","author":"Noda","year":"2015","journal-title":"Int J Surg"},{"issue":"3","key":"10.1016\/j.clbc.2026.05.009_bib0012","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/S12094-009-0333-y","article-title":"Predictive factors for non-sentinel lymph node involvement in breast cancer patients with a positive sentinel node: should we consider sentinel node-related factors?","volume":"11","author":"Fougo","year":"2009","journal-title":"Clin Trans Oncol"},{"key":"10.1016\/j.clbc.2026.05.009_bib0013","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.suronc.2019.11.008","article-title":"Sentinel node total tumour load as a predictive factor for non-sentinel node status in early breast cancer patients: the porttle study","volume":"32","author":"Luis Fougo","year":"2020","journal-title":"Surg Oncol"},{"key":"10.1016\/j.clbc.2026.05.009_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2022.101882","article-title":"Total tumor load to assist in the decision for additional axillary surgery in the positive sentinel node breast cancer patients","volume":"45","author":"Sousa","year":"2022","journal-title":"Surg Oncol"},{"key":"10.1016\/j.clbc.2026.05.009_bib0015","series-title":"AJCC cancer staging manual","author":"Edge","year":"2010"},{"issue":"1","key":"10.1016\/j.clbc.2026.05.009_bib0016","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10549-022-06727-9","article-title":"Axilla lymph node dissection can be safely omitted in patients with 1\u20132 positive sentinel nodes receiving mastectomy: a large multi-institutional study and a systemic meta-analysis","volume":"196","author":"Gao","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2026.05.009_bib0017","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znaf111","article-title":"Omitting completion axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases undergoing mastectomy: results from the prospective SENOMIC trial","volume":"112","author":"Andersson","year":"2025","journal-title":"BJS"},{"issue":"6","key":"10.1016\/j.clbc.2026.05.009_bib0018","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4174\/astr.2020.98.6.283","article-title":"Omission of axillary lymph node dissection in patients who underwent total mastectomy with 1 or 2 metastatic lymph nodes","volume":"98","author":"Kim","year":"2020","journal-title":"Ann Surg Treat Res"},{"issue":"1","key":"10.1016\/j.clbc.2026.05.009_bib0019","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41523-021-00336-3","article-title":"Sentinel node involvement with or without completion axillary lymph node dissection: treatment and pathologic results of randomized SERC trial","volume":"7","author":"Houvenaeghel","year":"2021","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2026.05.009_bib0020","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-5053-7","article-title":"Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial: axillary dissection versus no axillary dissection in patients with involved sentinel node","volume":"18","author":"Houvenaeghel","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clbc.2026.05.009_bib0021","first-page":"18","article-title":"The prevalence of non-sentinel lymph node metastasis among breast cancer patients with sentinel lymph node involvement and its impact on clinical decision-making: a single-centred retrospective study","author":"Ding","year":"2024","journal-title":"Oncol Rev"},{"issue":"2","key":"10.1016\/j.clbc.2026.05.009_bib0022","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1245\/s10434-025-18501-4","article-title":"Axillary management trends and survival in men undergoing mastectomy with positive sentinel nodes","volume":"33","author":"Fish","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.clbc.2026.05.009_bib0023","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1245\/s10434-024-15049-7","article-title":"Oncological safety of skipping axillary lymph node dissection in patients with clinical N0, sentinel node-positive breast cancer undergoing total mastectomy","volume":"31","author":"Chun","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2026.05.009_bib0024","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.4143\/crt.2018.438","article-title":"Axillary lymph node dissection does not improve post-mastectomy overall or disease-free survival among breast cancer patients with 1-3 positive nodes","volume":"51","author":"Joo","year":"2019","journal-title":"Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.clbc.2026.05.009_bib0025","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.21873\/invivo.11689","article-title":"Axillary dissection vs. no Axillary dissection in breast cancer patients with positive sentinel lymph node: a single institution experience","volume":"33","author":"Arisio","year":"2019","journal-title":"In Vivo"},{"issue":"4","key":"10.1016\/j.clbc.2026.05.009_bib0026","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"IBCSG 23-01 randomised controlled trial comparing axillary dissection versus no axillary dissection in patients with sentinel node micrometastases","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2026.05.009_bib0027","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","article-title":"Eight-year follow up result of the OTOASOR trial: the optimal treatment of the axilla: surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial","volume":"43","author":"S\u00e1volt","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"10.1016\/j.clbc.2026.05.009_bib0028","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2026.05.009_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.clbc.2025.03.007","article-title":"Post-mastectomy radiation therapy for intermediate-risk breast cancer patients with 0-3 positive axillary lymph nodes: emulating the SUPREMO trial using real-world data","author":"Kulkarni","year":"2025","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2026.05.009_bib0030","article-title":"Sentinel lymph node biopsy vs. axillary lymph node dissection for early-stage breast cancer and sentinel lymph node metastasis: an updated systematic review and meta-analysis with special focus on locoregional recurrence and regional node irradiation","volume":"19","author":"Agrawal","year":"2025","journal-title":"Breast Cancer"},{"issue":"7","key":"10.1016\/j.clbc.2026.05.009_bib0031","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/0284186X.2020.1745269","article-title":"Long-term follow-up on shoulder and arm morbidity in patients treated for early breast cancer","volume":"59","author":"Hauerslev","year":"2020","journal-title":"Acta Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2026.05.009_bib0032","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/lymphatics2030011","article-title":"Prevalence and quality of life in patients with lymphoedema following axillary clearance for breast and cutaneous malignancies","volume":"2","author":"Kim","year":"2024","journal-title":"Lymphatics"},{"key":"10.1016\/j.clbc.2026.05.009_bib0033","doi-asserted-by":"crossref","first-page":"104453","DOI":"10.1016\/j.breast.2025.104453","article-title":"CADONOT: comparing axillary dissection or not in breast cancer surgery","author":"Mattar","year":"2025","journal-title":"Breast"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926000820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926000820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:27:57Z","timestamp":1783481277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820926000820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1526820926000820"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.05.009","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Clinical Impact of Not Performing Axillary Lymph Node Dissection in pN+sn Breast Cancer Patients Undergoing Total Mastectomy","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}